Chinese researchers develop immunotherapeutic agent for colon cancer
Time:2024-05-22 02:41:12 Source:opinionsViews(143)
TIANJIN, March 15 (Xinhua) -- Chinese researchers have developed a novel immunotherapeutic agent for treating colon cancer, according to a recent article in the academic journal ACS Nano. In animal experiments, the agent, upon successful entry into tumor cells, can enhance T cell effector function to kill tumor cells and suppress colon tumor growth, according to Lu Chunwan from the School of Life Sciences of Tianjin University, one of the authors of the article. The agent can enhance tumor immunogenicity and inhibit colon tumor growth, with no significant impact on normal cells, said Lu. Colon cancer, characterized by its long latency period and high mortality rate, poses a severe threat to human health. Among various therapies, immunotherapy is considered one of the most promising treatment directions, according to Lu.
(Editor:Fu Bo)
share to:
Previous:Israeli army says it kills over 130 militants in E. Rafah
Next:Nadal returns to Roland Garros to practice amid doubts over fitness and form
Kind tips:The above content and pictures are compiled from the Internet and are for reference only. I hope they will be helpful to you! If there is any infringement, please contact us to delete it.!
You may also like
- Here comes the char
- China Focus: China Holds Central Economic Work Conference to Plan for 2023
- Chinese President Appoints New Ambassadors
- Xi, Angolan President Exchange Congratulations on 40th Anniversary of Diplomatic Ties
- California congressman urges closer consultation with tribes on offshore wind
- Xi Says China, GCC States Natural Partners for Cooperation
- Xi's Command in China's Battle Against COVID
- China, Philippines Cement Ties in New Year
- Sale continues dominant run as Braves beat Padres 3